Your browser doesn't support javascript.
loading
Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis.
Barreto, Savio George; Habtezion, Aida; Gukovskaya, Anna; Lugea, Aurelia; Jeon, Christie; Yadav, Dhiraj; Hegyi, Peter; Venglovecz, Viktória; Sutton, Robert; Pandol, Stephen J.
Afiliação
  • Barreto SG; Division of Surgery and Perioperative Medicine, Flinders Medical Center, Bedford Park, Adelaide, South Australia, Australia.
  • Habtezion A; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
  • Gukovskaya A; Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Lugea A; Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
  • Jeon C; Department of Medicine, West Los Angeles VA Healthcare Center, Los Angeles, California, USA.
  • Yadav D; Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Hegyi P; Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Venglovecz V; Division of Gastroenterology & Hepatology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Sutton R; First Department of Medicine, Faculty of Medicine, University of Szeged, Szeged, Hungary.
  • Pandol SJ; Institute for Translational Medicine and First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
Gut ; 70(1): 194-203, 2021 01.
Article em En | MEDLINE | ID: mdl-32973069
ABSTRACT
Acute pancreatitis (AP), an acute inflammatory disorder of the exocrine pancreas, is one of the most common gastrointestinal diseases encountered in emergency departments with no specific treatments. Laboratory-based research has formed the cornerstone of endeavours to decipher the pathophysiology of AP, because of the limitations of such study in human beings. While this has provided us with substantial understanding, we cannot answer several pressing questions. These are (a) Why is it that only a minority of individuals with gallstones, or who drink alcohol excessively, or are exposed to other causative factors develop AP? (b) Why do only some develop more severe manifestations of AP with necrosis and/or organ failure? (c) Why have we been unable to find an effective therapeutic for AP? This manuscript provides a state-of-the-art review of our current understanding of the pathophysiology of AP providing insights into the unanswered clinical questions. We describe multiple protective factors operating in most people, and multiple stressors that in a minority induce AP, independently or together, via amplification loops. We present testable hypotheses aimed at halting progression of severity for the development of effective treatments for this common unpredictable disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article